Centenarians as a model for healthy aging

被引:260
作者
Franceschi, C [1 ]
Bonafè, M
机构
[1] Univ Bologna, Dept Expt Pathol, Bologna, Italy
[2] Univ Bologna, Interdepartmental Ctr L Galvani Study Biocomplex, Bologna, Italy
[3] INRCA, Dept Gerontol Res, Ancona, Italy
关键词
aging centenarian; immunosenescence; inflammaging; longevity; T cells;
D O I
10.1042/BST0310457
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
For over 10 years we have studied centenarians as a model to address the biological basis of aging and longevity, with particular attention to immunology and genetics. The most important findings can be summarized as follows. (i) Human immunosenescence represents a complex remodelling, whereby cloncitypical immunity deteriorates, while ancestral, innate immunity is largely preserved. (ii) Continuous exposure to antigens causes a lifelong, chronic antigenic stress, which is responsible, together with the involution of the thymus, for the accumulation of memory/effector T cells and the exhaustion of naive T cells. (iii) Aging is characterized by a peculiar chronic inflammatory status that we propose to call 'inflammaging', which appears to be under genetic control, is detrimental for longevity and is more evident in men than in women. Inflammaging, i.e. the up-regulation of a variety of anti-stress responses at the cellular and molecular level, is the consequence of the ability of the body to adapt to and counteract the effects of a variety of stressors, which causes the accumulation of molecular and cellular scars. Inflammaging is considered the common and most important driving force of age-related pathologies, such as neurodegeneration, atherosclerosis, diabetes and sarcopenia, among others, all of which share an inflammatory pathogenesis. (iv) Possible strategies to counteract the major effects of immunosenescence and inflammaging, such as the systematic reduction of the lifelong antigenic load, the elimination of chronic infections, thymic rejuvenation and preventative treatment with anti-inflammatory drugs in people with a pro-inflammatory genotype, are envisaged.
引用
收藏
页码:457 / 461
页数:5
相关论文
共 30 条
  • [1] Dementia is not inevitable: A population-based study of Danish centenarians
    Andersen-Ranberg, K
    Vasegaard, L
    Jeune, B
    [J]. JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 2001, 56 (03): : P152 - P159
  • [2] Myocyte growth and cardiac repair
    Anversa, P
    Leri, A
    Kajstura, J
    Nadal-Ginard, B
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (02) : 91 - 105
  • [3] Age-associated changes in thymopoiesis
    Aspinall, R
    Andrew, D
    Pido-Lopez, J
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2002, 24 (01): : 87 - 101
  • [4] Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors
    Baggio, G
    Donazzan, S
    Monti, D
    Mari, D
    Martini, S
    Gabelli, C
    Dalla Vestra, M
    Previato, L
    Guido, M
    Pigozzo, S
    Cortella, I
    Crepaldi, G
    Franceschi, C
    [J]. FASEB JOURNAL, 1998, 12 (06) : 433 - 437
  • [5] Bagnara GP, 2000, J GERONTOL A-BIOL, V55, pB61
  • [6] C4, BF, C3 allele distribution and complement activity in healthy aged people and centenarians
    Bellavia, D
    Fradà, G
    Di Franco, P
    Feo, S
    Franceschi, C
    Sansoni, P
    Brai, M
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 1999, 54 (04): : B150 - B153
  • [7] Thymic regeneration: teaching an old immune system new tricks
    Berzins, SP
    Uldrich, AP
    Sutherland, JS
    Gill, J
    Miller, JFAP
    Godfrey, DI
    Boyd, RL
    [J]. TRENDS IN MOLECULAR MEDICINE, 2002, 8 (10) : 469 - 476
  • [8] The unexpected contribution of immunosenescence to the leveling off of cancer incidence and mortality in the oldest old
    Bonafè, M
    Valensin, S
    Gianni, W
    Marigliano, V
    Franceschi, C
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 39 (03) : 227 - 233
  • [9] Bonafè M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO
  • [10] 2-X